Extra Strength Pain Reliever Acetaminophen Recalled for cGMP Deviations
Ultra Seal Corporation is recalling Extra Strength Pain Reliever (acetaminophen 500 mg) 2 tablet packets nationwide due to cGMP deviations. The recall affects Lot #AK9602 with expiration date 05/2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for cGMP deviations without reported illnesses or injuries. The recall is voluntary and precautionary in nature, addressing manufacturing process defects rather than a confirmed product hazard.
Plain-English summary
Ultra Seal Corporation is recalling Extra Strength (ES) Pain Reliever tablets containing 500 mg acetaminophen in 2 tablet packets. The recall was initiated on January 24, 2022, and covers approximately 297,050 packets distributed nationwide within the United States.
The recall is due to Current Good Manufacturing Practice (cGMP) deviations identified during manufacturing. The affected product is Lot #AK9602 with expiration date 05/2022.
This is a voluntary recall initiated by the firm. The FDA classified this recall as Class II. The recall was terminated on October 16, 2023. Consumers who have purchased this product should discontinue use and consult with a healthcare provider or pharmacist if they have questions.
The recalled product
- Product
- Extra Strength (ES) PAIN RELIEVER (acetaminophen 500 mg) 2 tablet packets, Manufactured by Ultratab Laboratories, Inc.
- Manufacturer
- Ultra Seal Corporation
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AK9602
- Exp. Date 05/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- ModerateTopCare Earwax Removal Kit Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22